Massachusetts Financial Services’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-263,363
| Closed | -$753K | – | 912 |
|
|
2024
Q3 | $753K | Sell |
263,363
-6,378
| -2% | -$18.2K | ﹤0.01% | 804 |
|
|
2024
Q2 | $755K | Buy |
269,741
+9,054
| +3% | +$25.4K | ﹤0.01% | 810 |
|
|
2024
Q1 | $740K | Sell |
260,687
-575
| -0.2% | -$1.63K | ﹤0.01% | 796 |
|
|
2023
Q4 | $1.07M | Sell |
261,262
-8,252
| -3% | -$33.8K | ﹤0.01% | 767 |
|
|
2023
Q3 | $857K | Sell |
269,514
-10,328
| -4% | -$32.8K | ﹤0.01% | 775 |
|
|
2023
Q2 | $929K | Sell |
279,842
-6,594
| -2% | -$21.9K | ﹤0.01% | 753 |
|
|
2023
Q1 | $610K | Sell |
286,436
-8,099
| -3% | -$17.3K | ﹤0.01% | 795 |
|
|
2022
Q4 | $792K | Buy |
294,535
+6,234
| +2% | +$16.8K | ﹤0.01% | 794 |
|
|
2022
Q3 | $934K | Sell |
288,301
-2,627
| -0.9% | -$8.51K | ﹤0.01% | 785 |
|
|
2022
Q2 | $1.42M | Buy |
290,928
+1,470
| +0.5% | +$7.18K | ﹤0.01% | 752 |
|
|
2022
Q1 | $2.21M | Buy |
289,458
+38,496
| +15% | +$293K | ﹤0.01% | 745 |
|
|
2021
Q4 | $2.32M | Buy |
250,962
+90,457
| +56% | +$836K | ﹤0.01% | 765 |
|
|
2021
Q3 | $2.29M | Buy |
160,505
+25,622
| +19% | +$365K | ﹤0.01% | 771 |
|
|
2021
Q2 | $2.24M | Buy |
134,883
+102,563
| +317% | +$1.7M | ﹤0.01% | 765 |
|
|
2021
Q1 | $589K | Buy |
+32,320
| New | +$589K | ﹤0.01% | 873 |
|